CSF Neuropeptides in Euthymic Bipolar Patients and Controls
暂无分享,去创建一个
J. Nurnberger | G. Chrousos | P. Gold | R. Zerbe | T. Tomai | W. Berrettini | P. Gold
[1] N. Christensen,et al. Cerebrospinal Fluid Vasopressin—Changes in Depression , 1985, British Journal of Psychiatry.
[2] J. Nurnberger,et al. Neuropeptides in human cerebrospinal fluid. , 1985, Life sciences.
[3] J. Nurnberger,et al. Vasoactive intestinal peptide and bipolar affective illness. Evidence for an effect of lithium. , 1985, Journal of affective disorders.
[4] C. Kilts,et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. , 1984, Science.
[5] J. Rehfeld,et al. Vasoactive intestinal polypeptide decreased in cerebrospinal fluid (CSF) in atypical depression. Vasoactive intestinal polypeptide, cholecystokinin and gastrin in CSF in psychiatric disorders. , 1984, Journal of affective disorders.
[6] J. Nurnberger,et al. Muscarinic cholinergic receptors on skin fibroblasts in familial affective disorder. , 1984, The New England journal of medicine.
[7] J. Axelrod,et al. Stress hormones: their interaction and regulation. , 1984, Science.
[8] R. Post,et al. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. , 1984, The American journal of psychiatry.
[9] J. Nurnberger,et al. Genetic factors in affective illness. , 1984, Journal of psychiatric research.
[10] R. Post,et al. Prophylactic efficacy of carbamazepine in manic-depressive illness. , 1983, The American journal of psychiatry.
[11] W. Yau,et al. Neurotensin: a modulator of enteric cholinergic neurons in the guinea pig small intestine. , 1983, European journal of pharmacology.
[12] H. Kaji,et al. Release of vasoactive intestinal polypeptide into the cerebrospinal fluid of the fourth ventricle of the rat: Involvement of cholinergic mechanism , 1983, Brain Research.
[13] B. Carroll,et al. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. , 1983, Archives of general psychiatry.
[14] D. Rubinow,et al. CSF somatostatin in affective illness. , 1983, Archives of general psychiatry.
[15] J. Wood. Neuroendocrinology of cerebrospinal fluid: peptides, steroids, and other hormones. , 1982, Neurosurgery.
[16] G. Feuerstein,et al. Cardiovascular, sympathetic, and renin-angiotensin system responses to hemorrhage in vasopressin-deficient rats. , 1982, Endocrinology.
[17] F. Goodwin,et al. Peptides in the cerebrospinal fluid of neuropsychiatric patients: an approach to central nervous system peptide function. , 1982, Life sciences.
[18] R. Gerner,et al. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients , 1982, Brain Research.
[19] I. Jackson. Neural peptides in the cerebrospinal fluid. , 1981, Advances in biochemical psychopharmacology.
[20] J. Nurnberger,et al. Faster cholinergic REM sleep induction in euthymic patients with primary affective illness. , 1980, Science.
[21] T. Hökfelt,et al. Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[22] E. Gershon,et al. Genetic strategies in biological psychiatry. , 1978, Archives of general psychiatry.
[23] T. Ōkuma,et al. Anti‐Manic and Prophylactic Effects of Carbamazepine (Tegretol) on Manic Depressive Psychosis A Preliminary Report , 1973, Folia psychiatrica et neurologica japonica.
[24] H. Roffwarg,et al. Disrupted 24-hour patterns of cortisol secretion in psychotic depression. , 1973, Archives of general psychiatry.
[25] F. Greenwood,et al. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.